HealthcareServices

Gene Panel Market Outlook 2026–2035: Growth Drivers and Industry Forecast

February 27, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the gene panel market from 2026–2035 with trusted insights from The Business Research Company

How much larger will the Gene Panel Market be in 2030 compared with 2026?

The gene panel market has demonstrated rapid expansion in recent years. It is projected to expand from $2.47 billion in 2025 to $2.85 billion in 2026, progressing at a compound annual growth rate (CAGR) of 15.3%. This historical growth can be ascribed to several factors, including advancements in next-generation sequencing, a reduction in sequencing costs, increased adoption of clinical genetics, the expansion of diagnostic laboratories, and ongoing research into oncology biomarkers.

The gene panel market is anticipated to experience substantial growth in the upcoming years, with projections indicating it will reach $4.96 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.9%. This expansion during the forecast period is fueled by the advancement of personalized medicine, the enlargement of hereditary disease testing, the necessity for precision diagnostics, the integration of ai in genomic analysis, and increased clinical adoption. Prominent trends for this period include the rising adoption of multi-gene diagnostic panels, their expanded utilization in cancer risk assessment, the broadening of customized gene panel testing, an escalating demand for pharmacogenomic insights, and the incorporation of gene panels in clinical decision-making.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21190&type=smp

What Drivers Are Guiding Growth Patterns In The Gene Panel Market?

The increasing incidence of cancer is expected to boost the growth of the gene panel market in the future. Cancer describes a range of diseases characterized by uncontrolled cell proliferation and spread, which can invade and harm adjacent tissues and organs. The rise in cancer cases is attributed to factors like an aging population, shifts in lifestyle, environmental exposures, and advancements in detection and diagnostic technologies. Gene panels aid in cancer management by enabling thorough genetic testing to identify specific gene mutations and alterations, which can then guide personalized treatment strategies and improve outcomes for patients with cancer. For instance, in January 2023, according to the PubMed, a US-based free search engine for biomedical and life sciences literature maintained by the United States National Library of Medicine, it was reported that in 2023, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States. Therefore, the expanding prevalence of cancer is driving the growth of the gene panel market.

Which Segments Are Driving Activity In The Gene Panel Market?

The gene panel market covered in this report is segmented –

1) By Product And Services: Test Kits, Testing Services

2) By Technology: Amplicon-Based, Hybridization-Based, Other Technologies

3) By Design: Predesigned Gene Panel, Customized Gene Panel

4) By Application: Cancer Risk Assessment, Diagnosis Of Congenital Diseases, Pharmacogenetics, Other Applications

5) By End-User: Research Institutes, Hospital, Diagnosis Centers, Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Test Kits: Predesigned Gene Panels, Customized Gene Panels

2) By Testing Services: Cancer Risk Assessment Panels, Pharmacogenetic Testing Panels, Neurological Disorder Panels, Cardiovascular Disease Panels, Rare Disease Panels

Which Market Trends Are Opening Growth Opportunities In The Gene Panel Market?

Leading companies in the gene panel market are concentrating on developing innovative technologies, such as oncology panels, to enhance the accuracy, efficiency, and comprehensiveness of cancer diagnostics and personalized treatment strategies. Oncology panels are specialized gene panels that analyze multiple genes associated with cancer to identify genetic mutations and alterations, aiding in the diagnosis, prognosis, and treatment of cancer. For instance, in May 2023, Vizgen Inc., a US-based biotechnology company, launched the MERFISH PanCancer Pathways Panel, offering a customizable option for scientists entering the field of spatial genomics. These predesigned panels are tailored for various research applications, including cancer studies, and are optimized for enhanced error robustness, providing reliable and reproducible results. By integrating spatial information with gene expression data, the panels offer deeper insights into tumor microenvironments and cellular interactions, facilitating more targeted and personalized cancer research and therapeutic development. This launch represents a significant advancement in spatial biology, enabling researchers to explore complex biological systems with a level of detail previously unattainable.

Which Key Market Players Are Investing In Expansion And Innovation Within The Gene Panel Market?

Major companies operating in the gene panel market are F. Hoffmann-La Roche, Thermo Fisher Scientific, Quest Diagnostics, Eurofins Scientific, Agilent Technologies, Illumina, Qiagen, Myriad Genetics, Guardant Health, Invitae, Integrated DNA Technologies, Bio-Rad, Novogene, Fulgent Genetics, MedGenome, Centogene, Blueprint Genetics, BIONEER, BGI Group.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/gene-panel-global-market-report

Which Regions Are Projected To Dominate The Gene Panel Market In The Coming Years?

North America was the largest region in the gene panel market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gene panel market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Gene Panel Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21190&type=smp

Browse Through More Reports Similar to the Global Gene Panel Market 2026, By The Business Research Company

Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-global-market-report

Genes Therapy Market Report 2026

https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report

Gene Expression Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-expression-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795